[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU7855594A - Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them - Google Patents

Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them

Info

Publication number
AU7855594A
AU7855594A AU78555/94A AU7855594A AU7855594A AU 7855594 A AU7855594 A AU 7855594A AU 78555/94 A AU78555/94 A AU 78555/94A AU 7855594 A AU7855594 A AU 7855594A AU 7855594 A AU7855594 A AU 7855594A
Authority
AU
Australia
Prior art keywords
producing
controlled release
active
active substance
exhibiting rapid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78555/94A
Inventor
Kurt H. Bauer
Manfred Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of AU7855594A publication Critical patent/AU7855594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU78555/94A 1993-10-22 1994-10-12 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them Abandoned AU7855594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4336159 1993-10-22
DE4336159A DE4336159A1 (en) 1993-10-22 1993-10-22 Highly effective forms of preparation of sulfonylureas that release the active ingredient quickly or in a controlled manner and processes for their preparation
PCT/EP1994/003368 WO1995011006A1 (en) 1993-10-22 1994-10-12 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them

Publications (1)

Publication Number Publication Date
AU7855594A true AU7855594A (en) 1995-05-08

Family

ID=6500829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78555/94A Abandoned AU7855594A (en) 1993-10-22 1994-10-12 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them

Country Status (8)

Country Link
EP (1) EP0724427A1 (en)
JP (1) JPH09504015A (en)
AU (1) AU7855594A (en)
CA (1) CA2173366A1 (en)
DE (1) DE4336159A1 (en)
HU (1) HUT74684A (en)
NZ (1) NZ274501A (en)
WO (1) WO1995011006A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4064574B2 (en) * 1998-07-29 2008-03-19 株式会社資生堂 Anti-diabetic topical skin preparation
AP1243A (en) * 1999-02-01 2004-02-02 Servier Lab Core tablet for controlled release of gliclazide after oral administration.
JP5395327B2 (en) 2003-09-17 2014-01-22 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム Mechanism-based targeted pancreatic beta cell imaging and therapy
DE102004024440B4 (en) 2004-05-14 2020-06-25 Evonik Operations Gmbh Polymer powder with polyamide, use in a shaping process and molded body made from this polymer powder
DE202005021503U1 (en) 2005-02-19 2008-07-24 Evonik Degussa Gmbh Polymer powder with Blockpolyetheramid, use in a molding process and molding, made from this polymer powder
DE102005033379A1 (en) 2005-07-16 2007-01-18 Degussa Ag Use of cyclic oligomers in a molding process and molding made by this process
DE102006015791A1 (en) 2006-04-01 2007-10-04 Degussa Gmbh Polymer powder, process for the preparation and use of such a powder and molded articles thereof
DE102007019133A1 (en) 2007-04-20 2008-10-23 Evonik Degussa Gmbh Composite powder, use in a molding process and molding made from this powder
DE102008000755B4 (en) 2008-03-19 2019-12-12 Evonik Degussa Gmbh Copolyamide powder and its preparation, use of copolyamide powder in a molding process and molding, made from this copolyamide powder
EP2181705A1 (en) 2008-10-31 2010-05-05 Disphar International B.V. Sustained-release formulation of gliclazide
DE102011078720A1 (en) 2011-07-06 2013-01-10 Evonik Degussa Gmbh Powder comprising polymer-coated core particles containing metals, metal oxides, metal or metalloid nitrides
DE102011078719A1 (en) 2011-07-06 2013-01-10 Evonik Degussa Gmbh Powder containing polymer-coated particles
DE102011078721A1 (en) 2011-07-06 2013-01-10 Evonik Degussa Gmbh Powder containing polymer-coated polymeric core particles
DE102011078722A1 (en) 2011-07-06 2013-01-10 Evonik Degussa Gmbh Powder containing polymer-coated inorganic particles
DE102012205908A1 (en) 2012-04-11 2013-10-17 Evonik Industries Ag Polymer powder with adapted melting behavior
EP3455056B1 (en) 2016-05-13 2021-09-22 Hewlett-Packard Development Company, L.P. Material sets
US10717232B2 (en) 2016-05-13 2020-07-21 Hewlett-Packard Development Company, L.P. Material sets
DE202022000644U1 (en) 2022-03-15 2022-04-21 Evonik Operations Gmbh Powder for processing in a layer-by-layer process with visible and near-infrared lasers
EP4245506A1 (en) 2022-03-15 2023-09-20 Evonik Operations GmbH Powder for processing in a layer-by-layer method with lasers in the visible and near infrared range

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3927882A1 (en) * 1989-08-23 1991-02-28 Bauer Kurt Heinz HIGHLY EFFECTIVE, QUICK-ABSORBABLE PREPARATION FORMS OF GLIBENCLAMIDE, METHOD FOR THE PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
DE4336159A1 (en) 1995-04-27
HUT74684A (en) 1997-01-28
EP0724427A1 (en) 1996-08-07
JPH09504015A (en) 1997-04-22
WO1995011006A1 (en) 1995-04-27
NZ274501A (en) 1997-03-24
HU9600956D0 (en) 1996-06-28
CA2173366A1 (en) 1995-04-27

Similar Documents

Publication Publication Date Title
AU7855594A (en) Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them
AU1108695A (en) Aza-4-iminoquinolines, methods of preparing them and their use
AU5845394A (en) Biocompatible, surface modified materials and method of making the same
AU5337796A (en) Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
AU2082492A (en) Keratoprosthesis and method of producing the same
AU5422696A (en) Nox catalyst and method of using the same
AU3570193A (en) Altered antibodies, products and processes relating thereto
HUT72166A (en) Herbicides containing 4-benzoylisoxazole derivatives and process for producing the active ingredient
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
AU6391794A (en) Solid state spectrofluorimeter amd method of using the same
AU4939493A (en) Posts, beams and the like, and method of making same
AU5641798A (en) Artificial antibodies, method of producing the same and use thereof
AU5983696A (en) Fragile x related proteins, compositions and methods of maki ng and using the same
AU6372496A (en) Absorbent material, absorbent body made of the material, and method for the preparation of the material
AU7938294A (en) Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU4954193A (en) Fullerene derivatives, method of synthesizing them and their use
AU1314995A (en) Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use
AU673401B2 (en) 6,7-dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound
AU678566B2 (en) Antiulcer agent and process for preparing the same
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
AU692030B2 (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
AU7654094A (en) Microparticles, processes for their preparation and their use for the preparation of medicaments
AU7384894A (en) A method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
AU5348694A (en) Octahydronaphthoquinolizines, and methods of making and using thereof